Avalo Therapeutics, Inc. (AVTX): Depreciation & Amortization
$344.0K
Year ended 2025-12-31
$109.0K
Trailing 12 months to 2026-06-30
+27.5%
3-year compound annual growth
-28.5%
5-year compound annual growth
+30.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $344.0K | +103.6% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | $169.0K | +7.0% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | $158.0K | -4.8% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $166.0K | -90.0% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $1.66M | -10.1% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $1.84M | -52.5% | 2022-03-02, From 2020-01-01 |
| 2019-12-31 | $3.88M | -14.7% | 2021-03-08, From 2019-01-01 |
| 2018-12-31 | $4.55M | +970.6% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $425.5K | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $26.9K | +14.2% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $23.5K | n/a | 2018-04-02, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $344.0K | +103.6% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $704.0K | +6.7% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.04M | -12.0% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $246.0K | +138.8% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $173.0K | -12.2% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $11.54M | -41.2% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.15M | +2.3% |
| Talphera, Inc. (TLPH) | 2024-12-31 | $0 | -100.0% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $73.0K | -62.4% |
Compare AVTX, CNTB, HCWB, IXHL side by side · Screen every company in Pharmaceutical Preparations ↗